Ildong Pharmaceutical advances into the Chinese market for raw materials for hypertension treatment

Reporter Kim Jisun / approved : 2023-08-23 01:46:30
  • -
  • +
  • 인쇄
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Ildong Pharmaceutical Co. said on the 22nd that it has decided to export its cardiovascular raw material drug (API) Benidine Hydrochloride’ to Guangzhou Tosun Pharmaceutical in Guangzhou, China.

Benidipine is a calcium channel blocker (CCB) that expands blood vessels and relieves the burden on the heart by blocking the passage of calcium ions involved in the contraction of blood vessels and heart muscles, and is mainly used to treat high blood pressure and angina.

The company said it has recently signed a contract on a partnership between the two companies, including Tosun and Benidipine supply, and is carrying out all the necessary procedures to advance into China. Ildong Pharmaceutical had previously obtained registration and approval of raw materials for Benidipine from Chinese drug management authorities.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Bithumb Faces ‘Book-Entry Trading’ Concerns After Miscrediting Hundreds of Thousands of Bitcoins2026.02.07
Kolmar Korea Certified as Year’s First ‘Reshoring’ Company; To Invest 100 Billion KRW in Smart Factory Expansion2026.02.06
Court Dismisses Additional Lawsuits by Shareholders Over "Invossa" Controversy, Ruling in Favor of Kolon2026.02.06
Nvidia Delays China H200 Chip Exports Amid Ongoing Talks With U.S. Government2026.02.06
Naver Issues Formal Apology Over Exposure of Celebrities’ and Politicians’ Past "Ji-sik-iN" Posts2026.02.06
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사